Claim: Donald Trump owned stock in Thermo-Fisher Scientific at a time when his presidential administration was advocating for a COVID-19 test that uses Thermo-Fisher equipment.
Verdict: REFUTES

Retrieved passages:
title: Thermo Fisher Scientific
text: Thermo Fisher Scientific Thermo Fisher Scientific is an American biotechnology product development company located in Waltham, Massachusetts, and was created in 2006 by the merger of Thermo Electron and Fisher Scientific. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal that would rank the firm as one of the leading companies in the genetic testing and precision laboratory equipment markets. Thermo Electron was co-founded in 1956 by George N. Hatsopoulos and Peter M Nomikos. Hatsopoulos is a MIT PhD in mechanical engineering and Nomikos a Harvard Business

title: Fisher Scientific
text: 2004. In May 2006, Fisher Scientific and Thermo Electron announced that they would merge in a tax-free, stock-for-stock exchange. The merger closed on November 9, 2006 and the merged company is now called Thermo Fisher Scientific. The company was founded in Pittsburgh in 1902 by Chester Garfield Fisher (1881-1965), originally called the "Scientific Materials Co.". After obtaining his degree in engineering at Western University of Pennsylvania (now University of Pittsburgh), C.G. Fisher purchased the stockroom of the Pittsburgh Testing Laboratory. Fisher became a supplier of lab equipment and reagents for the area's industrial research. Early products included microscopes, burets, pipettes,

title: Thermo Fisher Scientific
text: School graduate. It focused on providing analytical and laboratory products and services, and had revenues of over $2 billion in 2004. Fisher Scientific was founded in 1902 by Chester G. Fisher from Pittsburgh. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. On May 14, 2006, Thermo Electron and Fisher Scientific announced that they would merge in a tax-free, stock-for-stock exchange; the merged company was named Thermo Fisher Scientific. On November 9, 2006, the companies announced that the merger had been completed. However, the Federal Trade Commission ruled that this acquisition

title: Thermo Electron
text: Fisher Scientific announced that they would merge in a tax-free, stock-for-stock exchange. The merged company became Thermo Fisher Scientific. On November 9, 2006, the companies announced that the merger had been completed. However, the Federal Trade Commission ruled that this acquisition was anticompetitive with regard to centrifugal evaporators, requiring Fisher to divest Genevac. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. Thermo Electron Thermo Electron Corporation (NYSE: TMO) (incorporated 1956) was a major provider of analytical instruments and services for a variety of domains. It was co-founded in 1956 by George

title: Thermo Fisher Scientific
text: 2017, the company acquired Finesse Solutions, Inc., developer of scalable control automation systems and software for bioproduction after receiving early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The transaction was completed a day later. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. In May, the company announced it would acquire CDMO, Patheon, for $7.2 billion. As of 2017, the company had revenues of $20.9 billion and was a Fortune 500 company. In September 2018, Thermo Fisher Scientific announced it had signed a definitive agreement with BD

title: Cole-Parmer
text: and to a facility eight years later. That same year, Cole-Parmer acquired Masterflex peristaltic pumps, followed shortly by the purchases of Gilmont Instruments and Manostat Pumps. They were acquired by Fisher Scientific, now Thermo-Fisher Scientific, in 2001. On July 17, 2014, Thermo Fisher Scientific Inc. agreed to sell one of its lab units, Cole-Parmer, to private-equity firm GTCR for $480 million in cash. The company has previously said its $13.6 billion acquisition of Life Technologies Corp. would allow it to cut costs while gaining from next-generation genetic-sequencing machines. It has also sought to expand in Asia-Pacific markets. Domestically, Cole-Parmer operates

title: Marijn Dekkers
text: became a director at the Boston-based Thermo Electron Corporation, one of the world's leading specialists in the manufacture of laboratory instruments. Within a short time, Dekkers implemented a complete corporate reorganization and became President and CEO in 2002. In this role, he initiated further extensive restructuring measures, divesting various organizational units and strengthening the company's core business by means of targeted acquisitions, including the purchase in 2006 of the laboratory consumables supplier Fisher Scientific. After the acquisition, the company renamed as Thermo Fisher Scientific, which employed 30,000 people in six business groups. On 1 January 2010 Dekkers was appointed to

title: Thermo Fisher Scientific
text: Scientific Inc. bought Phadia to expand in testing for allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash purchase. In 2013 Thermo Fisher agreed to buy Life Technologies for $13.6 billion. The sale was completed on 4 February 2014, and the Life Technologies brand became part of the Life Sciences Solutions Group of Thermo Fisher Scientific. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs, manufactures and delivers technologies used in bioprocessing solutions. In June 2015, the company announced its intention to acquire Alfa Aesar, a global manufacturer

title: Fisher Scientific
text: apparatus supply company E. Machlett & Sons. In 1962, the company installed an IBM computer system to record and track inventory levels for more than 40,000 items. Fisher Scientific Company issued its first public stock in 1965, and that year the company had $58 million in sales and close to a million customer transactions. In 1968 Fisher shares were listed on the New York Stock Exchange. In 1965 the company introduced the Differential Thermalyzer, a Differential thermal analysis instrument. It acquired Pfeiffer Glass, Inc. in 1966, manufacturer of high accuracy volumetric pipettes. The company released the Photometric Titralyzer that year,

title: Thermo Fisher Scientific
text: of research chemicals for $405 million from Johnson Matthey, and the acquisition was completed at the end of September In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research. In February

title: Fisher Scientific
text: August 2004, the company merged with Apogent Technologies Inc., a company engaged primarily in the manufacture and sale of laboratory products in the United States and other countries. In August 2017, Thermo Fisher acquired Patheon, a contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In September 2017, Thermo Fisher Scientific has signed an agreement with the Institute of Pathology Heidelberg (IPH) to establish its Center of Molecular Pathology at Heidelberg University Hospital as the newest member of the Next Generation Sequencing Companion Dx Center of Excellence Program (COEP). The initiative focuses on

title: Department of Defense Serum Repository
text: operated by Thermo Fisher Scientific under a no-bid or "sole-source" contract awarded in 2006. An earlier no-bid contract was awarded to Cryonix in 2005, although Cryonix was later incorporated under Thermo Electron Corporation's Biorepository Services division Thermo Electron subsequently merged with Fisher Scientific in 2006. Thermo Fisher's Fisher BioServices business currently holds the contract. The DoDSR consists of 15 large walk-in freezers, each approximately x 30 feet x 10 high, whose interiors are maintained at -30 °C by pairs of compressors. The majority of serum specimens are stored inside the walk-in freezers in cardboard boxes, approximately 6 x 18 x

title: Thermo Fisher Scientific
text: was anticompetitive with regard to centrifugal evaporators, requiring Fisher to divest Genevac. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. Currently, the company's products are sold under the brand names of Thermo Scientific, Fisher Scientific, and several other recognized brand names (e.g. Chromacol, Nalgene, Cellomics, Pierce Protein Research and Fermentas). According to company figures, 46% of its sales are in life sciences, 20% in healthcare, and 34% in industrial/environmental and safety. Thermo Fisher has offices and operations in many countries, notably the U.S. and in Europe. In May 2011, Thermo Fisher

title: Paul Montrone
text: a Captain in the U.S. Army. He later served as CEO of Wheelabrator Technologies. Montrone eventually became President and CEO of Fisher Scientific in 1991 and Chairman in 1998, resigning upon the company's merger with Thermo Electron in 2006. Montrone had been Executive Vice President of the Signal Companies, Inc. and its successor, AlliedSignal Inc. now Honeywell, President of the Henley Group, Inc. and Executive Vice President and CFO of Wheelabrator-Frye Inc. During the Clinton Administration, he was a member of the President’s Advisory Commission on Consumer Protection and Quality in the Health Care Industry, and a founder of the

title: Robert E. Finnigan
text: to detect such compounds, their monitoring and regulation would not have been possible. When Finnigan Instrument Corporation was acquired by Thermo Instrument Systems (later Thermo Fisher Scientific) in 1990, the firm was considered "the world's leading manufacturer of mass spectrometers". Robert Finnigan continued to consult for the company for several years after the acquisition. He has also consulted with other entrepreneurial companies. Robert Finnigan served on the board of directors of the trade organization American Electronics Association (AEA). He and Dean O. Morton were founders of the AEA's Environmental and Occupational Health activities. Finnigan also co-founded the Organization Internationale Metrology

title: John G. Trump
text: The unit was known as the "British Branch of the Radiation Laboratory" (BBRL) and operated as a department of Britain's Telecommunications Research Establishment (TRE) at Malvern, in Worcestershire. In 1943, as the technical aide in Division 14 of the NDRC, Trump reviewed and analyzed the papers of Nikola Tesla when the inventor died in a New York City hotel. The research was completed on behalf of the Alien property Custodian office in Washington DC. From February 1944 to the end of the war in Europe, Trump was the Director of the BBRL. During this time, Trump also served in the

title: Thermo Electron
text: Thermo Electron Thermo Electron Corporation (NYSE: TMO) (incorporated 1956) was a major provider of analytical instruments and services for a variety of domains. It was co-founded in 1956 by George N. Hatsopoulos, an MIT PhD in mechanical engineering, and Peter M. Nomikos, a Harvard Business School graduate. After graduating from Northeastern University in 1959 John Hatsopoulos (brother of George) joined the company as CFO. Arvin Smith joined the company in 1970, and was President from January 1998. In 2011, Thermo Fisher Scientific, its successor, had revenues of over $11 billion, and employed 37,000 people. On May 14, 2006, Thermo and

title: Thermo Fisher Scientific
text: (Becton, Dickinson and Company –NYSE: BDX) to acquire BD's Advanced Bioprocessing business. BD's Advanced Bioprocessing business has annualized revenue of approximately $100 million and as of October 16, 2018, has been integrated into Thermo Fisher's Life Sciences Solutions Segment. The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list): Source: Thermo Fisher Scientific Thermo Fisher Scientific is an American biotechnology product development company located in Waltham, Massachusetts, and was created in 2006 by the merger of Thermo Electron and Fisher Scientific. In April 2013, after a competitive bidding with

title: William U. Parfet
text: as president and CEO of Richard-Allan Medical Industries (now known as Thermo Fisher Scientific). He served on the board of trustees of the Financial Accounting Foundation, which oversees the Financial Accounting Standards Board, and as National Chairman of the Financial Executives Institute, now known as Financial Executives International (FEI). He served on the board of directors of PAREXEL from June 2001 to May 2006, and CMS Energy from November 1991 to May 2005. He joined MPI Research as co-chairman in November 1995 and served as chairman and chief executive officer from 1999 to 2016. He retired from MPI Research in

title: Fusion GPS
text: evidence that the Russian government paid for Fusion’s work on the Prevezon defense at the same time Fusion investigated Trump’s business dealings in Russia." In September 2015, Fusion GPS was hired by "The Washington Free Beacon", a conservative political website, to do opposition research on Trump and other Republican presidential candidates. In spring 2016 when Trump had emerged as the probable Republican candidate, the "Free Beacon" stopped funding investigation into Trump. From April 2016 through October 2016, the law firm Perkins Coie, on behalf of the Clinton campaign and the Democratic National Committee, retained Fusion GPS to continue opposition research